Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Singular Health (ASX:SHG) Advances US Commercialisation Plans for Medical Imaging Technology

• The company is expanding its United States presence as it pursues commercial opportunities for its specialist technology.

Aditi Sarkar | 04 November 2026

Star Combo Pharma (ASX:S66) Turns Attention to Health Products and Export Channels

• Star Combo Pharma disclosures mention its FY26 full-year reporting as part of its recent reporting record as described in the available information.

Aditi Sarkar | 04 November 2026

What does the appointment of Deborah Waterhouse as chief executive mean for CSL Limited (ASX:CSL) and the S&P/ASX 50 healthcare heavyweight?

It is too early to say whetherLeadershipalone will alter the company's trajectory, and the financial evidence below shows why caution is reasonable.

Sonal Goyal | 04 November 2026

What does the Virtua Health contract mean for Pro Medicus Ltd. (ASX:PME) in the S&P/ASX 50?

Pro Medicus develops and licenses medical imaging software. Its United States subsidiary, Visage Imaging, sells the Visage 7 platform, which includes a viewer, a workflow tool and an open archive, with cardiology imaging added for some clients.

Sonal Goyal | 04 November 2026

What does Sigma Healthcare's (ASX:SIG) UK store plan mean for the S&P/ASX 50 constituent after its FY26 result?

Sigma Healthcare (ASX:SIG) combines a pharmaceutical wholesaling and distributionBusinesswith the Chemist Warehouse retail andFranchisenetwork, following theMergercompleted in 2025. It supplies medicines and health products to pharmacies across Australia, operates and supports Chemist Warehouse branded stores, and also runs the Amcal and Discount Drug Stores …

Sonal Goyal | 04 November 2026

Vitrafy Life Sciences (ASX:VFY) Builds Its Cryopreservation Story Around US Expansion

Cryopreservation is the core of Vitrafy’s life-sciences offering. Its focus gives the company a defined position in a market where handling and preserving biological material is an important part of research and therapeutic processes. The company has been developing its technology while pursuing a …

Aditi Sarkar | 04 November 2026

Cyclopharm (ASX:CYC) Technegas US Expansion Brings Installations and Clinical Research Into View

• Company updates describe placements at major US hospital sites in the company’s disclosed business and operational updates.

Aditi Sarkar | 04 November 2026

Who Is Leading Resonance Health's (ASX:RHT) East-Coast Trial Site Expansion?

The executive has more than 25 years' experience across the clinical trial ecosystem, including investigator sites, research governance and global pharmaceutical and biotechnology organisations. Most recently, the executive worked at a clinical-stage biotechnology company responsible for clinical research across Phase I to III studies.

Sonal Goyal | 04 November 2026

What Vitrafy Life Sciences' (ASX:VFY) Q1 FY27 Results Reveal About Its US Cryopreservation Expansion

The third blood partnership, announced on 30 September 2026, was with Versiti Blood Health, a blood research organisation based in Milwaukee. Vitrafy will initially place two of its Guardion cryopreservation devices at Versiti's Blood Research Institute to advance development of no-wash platelet cryopreservation. Versiti …

Sonal Goyal | 03 November 2026

Why Saluda Medical (ASX:SLD) is backing a closed-loop paddle lead while managing a device field action

Saluda Medical, Inc. (ASX:SLD) is a commercial-stage medical device company with a neuromodulation platform for chronic neurological conditions. Its first product is the Evoke System, a closed-loop spinal cord stimulator.

Sonal Goyal | 03 November 2026
Support

Hi! How can we help you today?

Loading…